Dierenartsen Hond en Kat
0758.615.818 · rovalta.com · 26/09/2026
Dierenartsen Hond en Kat
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBODierenartsen Hond en Kat is a Private limited company incorporated in 2020. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Deinze.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0758.615.818
- Incorporation
- 20/11/2020
- Legal form
- Private limited company
- Registered office
- Emiel Clauslaan 134
9800 Deinze · FlandreSee on map - Contributed capital
- 2 000,00 €
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 4 filingsTrend over 4 financial years
| 2024 | 2023 | 2022 | 2021 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | 80 k € | +15.9% | 69 k € | +141% | 28,6 k € | +5.9% | 27 k € |
| EBITDA | 78,8 k € | +14.2% | 69 k € | +142% | 28,5 k € | +6.9% | 26,7 k € |
| Operating result | 78,8 k € | +14.2% | 69 k € | +142% | 28,5 k € | +8.8% | 26,2 k € |
| Net result | 57,6 k € | +14.0% | 50,6 k € | +174% | 18,5 k € | +10.5% | 16,7 k € |
| Balance sheet | |||||||
| Equity | 2,1 k € | -61.5% | 5,5 k € | +7175% | -77,6 € | -104% | 2 k € |
| Total assets | 321,3 k € | +6.1% | 302,9 k € | +22.5% | 247,3 k € | +3.0% | 240,2 k € |
| Cash | 167 k € | +2.3% | 163,2 k € | +36.2% | 119,8 k € | -25.2% | 160,2 k € |
| Debts | 255,2 k € | -11.7% | 289,1 k € | +22.1% | 236,8 k € | +0.1% | 236,6 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20243 active · 5 ended
Active mandates
Ended mandates
Other companies at this address
Emiel Clauslaan 134 9800 Deinze| Company | CBE no. |
|---|---|
Hond en Kat● Active | 0758.852.180 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 20/11/2020 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 14 months |
| Filing date | 07/11/2025 | 28/06/2024 | 22/05/2023 | 12/05/2022 |
| General meeting | 31/10/2025 | 23/04/2024 | 22/04/2023 | 22/04/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 4 filingsValuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20243 active · 5 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 202457,6 k €↑
- 2023Annual accounts 202350,6 k €↑
- 2022Annual accounts 202218,5 k €↑
- 2021Annual accounts 202116,7 k €
- 20/11/2020IncorporationPrivate limited company